epsteinbarr
viru
ebv
associ
nasopharyng
carcinoma
npc
remain
obscur
whether
ebv
viral
caus
accompani
npc
discuss
accumul
evid
point
relationship
ebv
infect
npc
initi
epidemiolog
pathogen
molecular
oncogen
experiment
anim
studi
believ
convinc
evid
perspect
must
provid
ascertain
causal
role
ebv
infect
npc
specif
epidemiolog
studi
reveal
ebv
infect
risk
factor
introduct
ebv
anim
model
produc
npc
anim
model
npc
main
molecular
event
involv
signal
pathway
ident
human
npc
final
importantli
prevent
ebv
infect
clearanc
ebv
infect
individu
must
abl
reduc
incid
rate
npc
viral
caus
infecti
diseas
establish
fulfil
koch
postul
modifi
river
six
criteria
requir
univers
presenc
viru
everi
diseas
host
isol
host
cultiv
pure
cultur
product
compar
diseas
inject
viru
suitabl
recipi
reisol
viru
detect
specif
immun
respons
viru
new
human
infecti
diseas
sar
sever
acut
respiratori
syndrom
broke
criteria
help
establish
causal
relationship
sar
sarsassoci
coronaviru
howev
unlik
infecti
diseas
cancer
occurr
complex
chronic
process
associ
caus
relationship
viru
carcinogenesi
debat
long
time
virus
verifi
cancer
epsteinbarr
viru
ebv
first
viru
detect
within
human
cancer
cell
epstein
group
discern
viruslik
particl
electron
microscopi
cell
line
deriv
burkitt
lymphoma
follow
year
signific
discoveri
help
establish
relationship
virus
tumor
includ
recoveri
hepat
b
viru
hbv
particl
serum
patient
hepat
isol
human
tcell
leukemia
viru
lymphocyt
patient
cutan
tcell
lymphoma
identif
human
herpesviru
caus
kaposi
sarcoma
howev
role
ebv
npc
initi
far
difficult
clarifi
ebv
member
herpesviru
famili
infect
world
popul
primari
infect
usual
occur
childhood
asymptomat
develop
countri
western
countri
ebv
infect
may
delay
adolesc
usual
occurr
infecti
mononucleosi
ebv
exist
human
host
without
seriou
consequ
lifetim
nasopharyng
carcinoma
npc
consid
associ
ebv
infect
whether
ebv
play
causal
role
npc
associ
develop
remain
controversi
articl
discuss
relationship
ebv
infect
npc
initi
epidemiolog
studi
provid
primari
essenti
evid
relationship
diseas
causal
agent
initi
link
ebv
infect
npc
discov
serolog
analysi
antibodi
titer
ebv
higher
sera
npc
patient
sera
patient
burkitt
lymphoma
later
found
npc
usual
exhibit
high
ebv
serolog
profil
wherev
occur
whether
endem
nonendem
area
npc
patient
high
immunoglobulin
andor
igg
level
variou
ebv
antigen
includ
viral
capsid
antigen
vca
diffus
earli
antigen
ead
viral
nuclear
antigen
glycoprotein
transcript
activ
zta
rta
elev
ebv
antibodi
titer
report
preced
develop
detect
npc
sever
year
strengthen
impress
ebv
might
etiolog
factor
npc
even
though
ebv
infect
ubiquit
human
incid
npc
vari
geograph
area
npc
rare
mani
part
world
includ
europ
north
america
moder
incid
found
african
mediterranean
popul
inuit
greenland
alaska
malay
singapor
malaysia
highest
incid
occur
peopl
southern
china
southeast
asia
particularli
cantones
emigr
southern
china
lower
incid
still
retain
higher
risk
npc
western
popul
also
risk
npc
among
caucasian
born
china
southeast
asia
higher
rel
westernborn
caucasian
thu
fact
univers
ebv
infect
specif
endem
racial
npc
distribut
suggest
nonvir
factor
environment
carcinogen
genet
may
play
import
role
npc
initi
ebv
infect
famili
cluster
npc
often
observ
consid
good
model
studi
npc
etiolog
ebv
causal
factor
high
risk
npc
higher
ebv
antibodi
reactiv
healthi
control
popul
although
one
studi
show
unaffect
individu
highrisk
npc
famili
higher
antiebv
antibodi
titr
studi
find
differ
ebv
serolog
unaffect
famili
member
healthi
control
popul
reason
discrep
remain
unknown
suggest
ebv
might
initi
factor
npc
onset
recent
one
studi
base
epidemiolog
vitro
experiment
data
show
smoke
could
result
ebv
activ
therefor
believ
nonvir
factor
eg
genet
factor
requir
host
cell
carcinogenesi
accompani
ebv
activ
genomewid
linkag
scan
run
distinct
seri
famili
south
china
differ
predisposit
loci
found
although
data
consist
suscept
gene
common
lifestyl
might
contribut
npc
given
strong
famili
aggreg
idea
ebv
involv
npc
initi
come
part
observ
npc
tissu
contain
monoclon
viral
episom
ident
terminu
number
upon
entri
cell
linear
ebv
dna
circular
termin
repeat
form
intracellular
episom
circular
event
fuse
termini
uniqu
length
unlik
length
heterogen
cell
popul
primari
infect
ident
termin
repeat
valu
ebv
dna
found
npc
sampl
clonal
data
hypothes
npc
tumor
repres
outgrowth
singl
infect
progenitor
time
initi
howev
vitro
experi
ebv
infect
establish
epitheli
cell
line
shown
npc
cell
line
initi
polyclon
rapidli
follow
predomin
clonal
pattern
thu
ebv
clonal
may
consequ
select
growth
advantag
display
specif
viral
episom
argu
hypothesi
ebv
present
prior
clonal
expans
malign
cell
furthermor
although
sampl
invas
npc
npc
situ
posit
examin
situ
hybrid
ebvencod
rna
eber
ebv
rnaneg
cell
observ
everi
npc
biopsi
specimen
small
fraction
npc
cell
contain
viru
ebvposit
cell
line
sever
npc
cell
line
even
ebvfre
rel
b
lymphocyt
epitheli
cell
express
receptor
make
differ
ebv
infect
ebv
infect
npc
cell
contact
ebviga
polymer
immunoglobulin
receptor
pigr
untransform
squamou
metaplast
epitheli
cell
nasopharyng
mucosa
pigrneg
ebv
infect
cell
ebv
infect
normal
nasopharyng
cell
rare
ebv
detect
normal
nasopharyng
biopsi
individu
high
risk
develop
npc
normal
mucosa
adjac
ebvposit
npc
yet
pigr
protein
express
tumor
cell
salivari
gland
epitheli
cell
might
explain
ebv
genom
less
frequent
detect
untransform
nasopharyng
epitheli
cell
among
nasopharyng
biopsi
tissu
variou
neoplast
stage
analyz
pcr
case
invas
npc
case
situ
npc
posit
ebv
dnase
healthi
subject
elev
ebv
antibodi
level
dnaseposit
togeth
long
latenc
primari
ebv
infect
npc
develop
result
suggest
ebv
infect
first
event
npc
pathogenesi
one
studi
specimen
nasopharyng
lymphoid
hyperplasia
contain
ebv
dna
npc
found
among
individu
five
year
followup
consid
loss
chromosom
normal
nasopharyng
mucosa
lowgrad
dysplast
lesion
individu
highrisk
npc
region
possibl
genet
abnorm
nasopharyng
epithelium
caus
predisposit
ebv
infect
origin
adjac
lymphoid
tissu
circul
bcell
exampl
npc
cell
line
immort
overexpress
cellular
oncogen
ebv
could
infect
cell
higher
effici
suggest
host
oncogen
could
favor
ebv
infect
studi
oncogen
mechan
cell
line
import
verifi
inform
deriv
epidemiolog
observ
consid
ebv
oncogen
transform
rodent
fibroblast
cell
line
produc
loss
contact
inhibit
cell
caus
anchorageindepend
growth
balbc
cell
clone
high
effici
vitro
cell
transform
tumorigen
nude
mice
cell
without
express
also
signific
effect
epitheli
cell
growth
induc
epiderm
hyperplasia
express
skin
transgen
mice
howev
transform
epitheli
cell
effici
detect
npc
case
evid
indic
npc
aggress
tumor
recent
report
induc
npc
stemlik
cancer
cell
caus
high
tumorigen
rapid
cell
prolifer
thu
might
contribut
npc
progress
activ
variou
signal
pathway
regul
express
host
gene
encod
protein
involv
tumor
progress
invas
cyclin
vegf
proinflamm
cytokin
although
ebv
infect
transform
b
lymphocyt
effici
vitro
epitheli
infect
much
less
effici
transform
normal
human
epitheli
cell
ebv
depend
presenc
phorbol
ester
produc
plant
particularli
plant
use
herbal
medicin
plant
grow
within
geograph
area
npc
preval
south
china
establish
cell
model
ebv
infect
epitheli
cell
replic
vivo
situat
would
provid
import
insight
relationship
ebv
npc
anim
experi
provid
direct
inform
relationship
carcinogen
agent
carcinoma
success
exampl
includ
mongolian
gerbil
infect
h
pylori
studi
gastric
carcinoma
hbv
transgen
mice
studi
liver
cancer
appropri
anim
model
play
import
role
evalu
infecti
agent
carcinogenesi
ebv
human
viru
high
degre
speci
specif
studi
viru
vivo
difficult
two
strategi
build
anim
model
ebv
ebvlik
infect
could
partli
reproduc
cellviru
relationship
either
symptomat
primari
infect
human
ebvassoci
carcinoma
one
challeng
anim
ebv
studi
virushost
relationship
use
host
resid
inocul
sever
combin
immunodefici
scid
mice
ebvinfect
b
cell
result
viral
load
develop
malign
lymphoma
model
system
host
cell
never
infect
ebv
model
inappropri
test
initi
npc
ebv
infect
human
mous
model
ebv
infect
establish
model
human
b
natur
killer
cell
reconstitut
ebv
could
infect
grow
b
cell
result
b
cell
lymphoprolif
disord
whether
model
could
use
studi
ebvnpc
relat
warrant
investig
primat
similar
human
three
speci
new
world
monkey
experiment
infect
ebv
exampl
inocul
ebv
high
titer
cotton
tamarin
cottontop
marmoset
owl
monkey
develop
illdefin
infecti
mononucleosislik
syndrom
multipl
lymphoma
howev
speci
gener
challeng
intraperiton
rout
rather
oral
mean
viruscel
relationship
establish
differ
human
mucos
surfac
furthermor
primat
model
establish
persist
ebv
infect
crossspeci
viru
infect
suggest
precis
mimic
human
respons
ebv
infect
murin
rhesu
lymphocryptoviru
lcv
contain
genet
sequenc
immun
control
similar
human
ebv
use
model
persist
bcell
infect
bcell
lymphomagenesi
lcv
epitheli
cell
infect
esophagu
andor
tongu
observ
immunosuppress
rhesu
macaqu
similar
ebvinduc
epitheli
cell
abnorm
aid
howev
report
lcv
infect
result
nasopharyng
malign
establish
etiolog
factor
certain
malign
particularli
etiolog
role
ebv
npc
initi
believ
follow
criteria
modifi
koch
postul
fulfil
epidemiolog
studi
provid
evid
propos
factor
independ
risk
factor
cancer
incid
introduct
propos
factor
anim
model
produc
malign
mirror
human
diseas
animalmodel
diseas
main
molecular
event
main
signal
pathway
involv
ident
human
malign
final
importantli
prevent
propos
factor
enter
suscept
popul
clearanc
propos
factor
treatment
vaccin
case
ebv
highrisk
popul
must
significantli
reduc
incid
rate
malign
vaccin
effect
econom
prevent
approach
viral
infect
vaccin
cancer
virus
potenti
reduc
cancer
rate
success
develop
hbv
hpv
vaccin
demonstr
concept
hbv
vaccin
use
year
prevent
viral
transmiss
newborn
result
lifelong
infect
effect
hbv
vaccin
reduc
liver
cancer
clear
year
hpv
vaccin
provid
protect
persist
hpv
infect
five
year
vaccin
order
clarifi
etiolog
role
ebv
npc
believ
convinc
evid
declin
npc
incid
rate
endem
area
prevent
ebv
infect
first
report
immun
respons
purifi
nativ
recombin
previous
term
ebv
protein
could
protect
ebvinduc
lymphoma
cottontop
tamarin
later
vacciniadeliv
vaccin
report
protect
infant
ebv
infect
clinic
trial
month
recent
year
ebv
vaccin
contain
differ
antigen
develop
test
phase
iii
clinic
trial
vaccin
taken
advancedstag
trial
although
recombin
vaccin
could
reduc
incid
im
could
prevent
asymptomat
ebv
infect
importantli
evid
thu
far
show
ebv
vaccin
effect
protect
anim
model
npc
initi
tumor
initi
usual
complex
multistep
process
involv
environment
biolog
genet
factor
tumor
virus
may
play
import
role
carcinogenesi
might
also
contribut
toward
uncov
cell
growth
pathway
cancer
although
clinic
serolog
data
suggest
associ
ebv
npc
evid
mechanist
studi
anim
bioassay
role
ebv
infect
npc
occurr
weaker
role
ebv
lymphoma
furthermor
fact
univers
ebv
infect
mark
geograph
racial
distribut
highincid
npc
suggest
cofactor
may
play
import
role
npc
initi
futur
studi
fulfil
propos
criteria
need
clarifi
role
ebv
infect
npc
initi
would
solv
mysteri
ebv
biolog
also
provid
benefit
npc
prevent
treatment
